Health journalists

Women the use of weight-loss jabs are being instructed to forestall if they’re attempting for a toddler, have fallen pregnant or are breastfeeding.
Drug protection mavens in the United Kingdom say it is not identified whether or not taking the drugs, equivalent to Wegovy and Mounjaro, may just hurt an unborn child.
The recommendation already seems in affected person data leaflets that include the drugs.
But there are issues that the rising approval for ‘thin jabs’ method many ladies are not the use of the medication safely or getting the suitable recommendation.

Natasha Major, 26, began the use of Mounjaro to drop extra pounds ahead of making plans to check out for her 3rd child in a couple of years’ time, however used to be stunned six weeks later to search out she used to be pregnant. She used to be taking the contraceptive tablet on the time.
“I have polycystic ovaries as well, so I can’t get pregnant easily or quickly. So it was an even bigger shock that I had, which didn’t make any sense to me,” she says.
She then apprehensive she may well be harming the newborn or it would not broaden correctly, so she rang her GP for recommendation, who informed her to forestall taking it.
“We’re over the initial shock now and really happy, just wasn’t expected,” she says.
“The last injection I took, I found out about the pregnancy three hours later and haven’t taken it since then.
“I’ve had an early scan to ensure the being pregnant used to be viable and ok – child had a little bit heartbeat and the whole lot appears excellent,” Natasha says.
The UK drugs regulator, as well as doctors and pharmacists, are worried that popular GLP-1 medicines, known as Wegovy, Mounjaro, Saxenda, Victoza and Ozempic, are not being used safely.
These prescription medicines, which are licensed to treat obesity (and Ozempic for type 2 diabetes), make people feel full by mimicking a hormone released after eating. Mounjaro also acts on another hormone linked to appetite and blood sugar control.
They are only available on the NHS to people with a very high BMI, but such is the demand for them that many people are buying them from unregulated sellers on social media or from beauty salons, without any medical advice, as a quick fix to lose weight.
As a precaution, the Medicines and Healthcare products Regulatory Agency (MHRA) says women should use contraception while taking GLP-1 medicines and for a certain period afterwards before trying to become pregnant – two months for Wegovy and Ozempic, and one month for Mounjaro.
It also advises that those using Mounjaro and taking an oral contraceptive should also use a condom for four weeks after starting the drug, or switch to another method such as the coil or implant.
Weight-loss jabs may make the contraceptive pill less likely to work in those who are overweight or obese, the MHRA says.
Women should be told this information when they starting taking the jabs, but there are fears the message is not getting through.
Natasha bought Mounjaro online and says she “can not bear in mind studying the rest about birth control on there”.
The MHRA has produced new guidance on weight-loss jabs for people taking them.
It’s acted now because of a very small number of reports of unintended pregnancies and complications in pregnancy made to its Yellow Card scheme, where the public can report suspected side-effects of medicines.
Dr Alison Cave, chief safety officer at the MHRA, said there was evidence from animal studies “that those drugs would possibly hurt the unborn child”.
“But we do not know whether or not we’ve got the similar results in people, so a lot more information is had to decide that.”
Women of child-bearing age are usually not included in clinical trials, which is why there is a lack of safety information for them.
“If you’re taking this medication and you might be pregnant, you must communicate in your physician about preventing the medication once imaginable,” she said.
Sukhi Basra, vice-chairwoman of the National Pharmacy Association, said women should visit their pharmacist for advice if they are confused about when to stop using the drugs.
When it comes to accessing contraception, BPAS, the British Pregnancy Advisory Service, says women in the UK “face important demanding situations” when trying to access their method of choice.
A loss of appointments, lengthy ready lists and top prices are simply one of the crucial obstacles they face, BPAS stated, because it known as for a greater plan for offering the selection girls want.